RA Capital Management’s Latigo Biotherapeutics LTGO Stock Holding History
Bought
Maintained
Sold
Other funds holding LTGO
RA Capital Management's LTGO Position: Q3 2026 in Review
RA Capital Management opened a new position in Latigo Biotherapeutics (LTGO) in Q3 2026: 5,302,933 shares worth $88.6M. The stake represents 0.89% of the portfolio and ranks #24 among its holdings.
58 funds tracked by Wall St. Rank hold LTGO as of Q3 2026.
- RA Capital Management held 5,302,933 shares of Latigo Biotherapeutics worth $88.6M as of Q3 2026.
- Latigo Biotherapeutics was a new RA Capital Management position in Q3 2026.
- Latigo Biotherapeutics made up 0.89% of RA Capital Management's portfolio in Q3 2026, its #24 holding.
- 58 funds tracked by Wall St. Rank held Latigo Biotherapeutics as of Q3 2026.
Based on RA Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.